Cargando…

Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches

BACKGROUND: Extensive clinical and experimental research documents the potential for chemical disruption of thyroid hormone (TH) signaling through multiple molecular targets. Perturbation of TH signaling can lead to abnormal brain development, cognitive impairments, and other adverse outcomes in hum...

Descripción completa

Detalles Bibliográficos
Autores principales: Noyes, Pamela D., Friedman, Katie Paul, Browne, Patience, Haselman, Jonathan T., Gilbert, Mary E., Hornung, Michael W., Barone, Stan, Crofton, Kevin M., Laws, Susan C., Stoker, Tammy E., Simmons, Steven O., Tietge, Joseph E., Degitz, Sigmund J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Environmental Health Perspectives 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791490/
https://www.ncbi.nlm.nih.gov/pubmed/31487205
http://dx.doi.org/10.1289/EHP5297
_version_ 1783458985933799424
author Noyes, Pamela D.
Friedman, Katie Paul
Browne, Patience
Haselman, Jonathan T.
Gilbert, Mary E.
Hornung, Michael W.
Barone, Stan
Crofton, Kevin M.
Laws, Susan C.
Stoker, Tammy E.
Simmons, Steven O.
Tietge, Joseph E.
Degitz, Sigmund J.
author_facet Noyes, Pamela D.
Friedman, Katie Paul
Browne, Patience
Haselman, Jonathan T.
Gilbert, Mary E.
Hornung, Michael W.
Barone, Stan
Crofton, Kevin M.
Laws, Susan C.
Stoker, Tammy E.
Simmons, Steven O.
Tietge, Joseph E.
Degitz, Sigmund J.
author_sort Noyes, Pamela D.
collection PubMed
description BACKGROUND: Extensive clinical and experimental research documents the potential for chemical disruption of thyroid hormone (TH) signaling through multiple molecular targets. Perturbation of TH signaling can lead to abnormal brain development, cognitive impairments, and other adverse outcomes in humans and wildlife. To increase chemical safety screening efficiency and reduce vertebrate animal testing, in vitro assays that identify chemical interactions with molecular targets of the thyroid system have been developed and implemented. OBJECTIVES: We present an adverse outcome pathway (AOP) network to link data derived from in vitro assays that measure chemical interactions with thyroid molecular targets to downstream events and adverse outcomes traditionally derived from in vivo testing. We examine the role of new in vitro technologies, in the context of the AOP network, in facilitating consideration of several important regulatory and biological challenges in characterizing chemicals that exert effects through a thyroid mechanism. DISCUSSION: There is a substantial body of knowledge describing chemical effects on molecular and physiological regulation of TH signaling and associated adverse outcomes. Until recently, few alternative nonanimal assays were available to interrogate chemical effects on TH signaling. With the development of these new tools, screening large libraries of chemicals for interactions with molecular targets of the thyroid is now possible. Measuring early chemical interactions with targets in the thyroid pathway provides a means of linking adverse outcomes, which may be influenced by many biological processes, to a thyroid mechanism. However, the use of in vitro assays beyond chemical screening is complicated by continuing limits in our knowledge of TH signaling in important life stages and tissues, such as during fetal brain development. Nonetheless, the thyroid AOP network provides an ideal tool for defining causal linkages of a chemical exerting thyroid-dependent effects and identifying research needs to quantify these effects in support of regulatory decision making. https://doi.org/10.1289/EHP5297
format Online
Article
Text
id pubmed-6791490
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Environmental Health Perspectives
record_format MEDLINE/PubMed
spelling pubmed-67914902019-11-06 Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches Noyes, Pamela D. Friedman, Katie Paul Browne, Patience Haselman, Jonathan T. Gilbert, Mary E. Hornung, Michael W. Barone, Stan Crofton, Kevin M. Laws, Susan C. Stoker, Tammy E. Simmons, Steven O. Tietge, Joseph E. Degitz, Sigmund J. Environ Health Perspect Commentary BACKGROUND: Extensive clinical and experimental research documents the potential for chemical disruption of thyroid hormone (TH) signaling through multiple molecular targets. Perturbation of TH signaling can lead to abnormal brain development, cognitive impairments, and other adverse outcomes in humans and wildlife. To increase chemical safety screening efficiency and reduce vertebrate animal testing, in vitro assays that identify chemical interactions with molecular targets of the thyroid system have been developed and implemented. OBJECTIVES: We present an adverse outcome pathway (AOP) network to link data derived from in vitro assays that measure chemical interactions with thyroid molecular targets to downstream events and adverse outcomes traditionally derived from in vivo testing. We examine the role of new in vitro technologies, in the context of the AOP network, in facilitating consideration of several important regulatory and biological challenges in characterizing chemicals that exert effects through a thyroid mechanism. DISCUSSION: There is a substantial body of knowledge describing chemical effects on molecular and physiological regulation of TH signaling and associated adverse outcomes. Until recently, few alternative nonanimal assays were available to interrogate chemical effects on TH signaling. With the development of these new tools, screening large libraries of chemicals for interactions with molecular targets of the thyroid is now possible. Measuring early chemical interactions with targets in the thyroid pathway provides a means of linking adverse outcomes, which may be influenced by many biological processes, to a thyroid mechanism. However, the use of in vitro assays beyond chemical screening is complicated by continuing limits in our knowledge of TH signaling in important life stages and tissues, such as during fetal brain development. Nonetheless, the thyroid AOP network provides an ideal tool for defining causal linkages of a chemical exerting thyroid-dependent effects and identifying research needs to quantify these effects in support of regulatory decision making. https://doi.org/10.1289/EHP5297 Environmental Health Perspectives 2019-09-05 /pmc/articles/PMC6791490/ /pubmed/31487205 http://dx.doi.org/10.1289/EHP5297 Text en EHP is an open-access journal published with support from the National Institute of Environmental Health Sciences, National Institutes of Health. All content is public domain unless otherwise noted.
spellingShingle Commentary
Noyes, Pamela D.
Friedman, Katie Paul
Browne, Patience
Haselman, Jonathan T.
Gilbert, Mary E.
Hornung, Michael W.
Barone, Stan
Crofton, Kevin M.
Laws, Susan C.
Stoker, Tammy E.
Simmons, Steven O.
Tietge, Joseph E.
Degitz, Sigmund J.
Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches
title Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches
title_full Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches
title_fullStr Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches
title_full_unstemmed Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches
title_short Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches
title_sort evaluating chemicals for thyroid disruption: opportunities and challenges with in vitro testing and adverse outcome pathway approaches
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791490/
https://www.ncbi.nlm.nih.gov/pubmed/31487205
http://dx.doi.org/10.1289/EHP5297
work_keys_str_mv AT noyespamelad evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches
AT friedmankatiepaul evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches
AT brownepatience evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches
AT haselmanjonathant evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches
AT gilbertmarye evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches
AT hornungmichaelw evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches
AT baronestan evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches
AT croftonkevinm evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches
AT lawssusanc evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches
AT stokertammye evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches
AT simmonssteveno evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches
AT tietgejosephe evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches
AT degitzsigmundj evaluatingchemicalsforthyroiddisruptionopportunitiesandchallengeswithinvitrotestingandadverseoutcomepathwayapproaches